"Somewhere between September and February of this year, everybody and their brother, from celebrities to housewives to grandmothers, have sort of gotten their hands on or have heard about or know somebody who's on one of these GLP-1's ones with really good results," said Ciafardoni
Since launching its rolling BLA submission in December under an Accelerated Approval pathway, Sangamo has submitted preclinical and clinical modules, as well as submitted its antibody assay companion diagnostic, designed to screen patients for eligibility with isaralgagene civaparvovec, to the FDAs Center for Devices and Radiological Health (CDRH), seeking Premarket Approval (PMA).
Dose for Month 4, inject 0.3cc subcutaneously once a week
There's no prescription drug containing BPC-157 that's legally approved for human use in treating injuries, inflammation, gut issues, or pain